[en] OBJECTIVE: To determine whether delivery of methylprednisolone to the round window (administered for 10 days after the onset of the hearing loss) can improve hearing and, in particular, speech intelligibility, after the failure of conventional treatment for idiopathic sudden sensorineural hearing loss. RESULTS: Of the 26 patients enrolled in this non-randomized retrospective study, 14 patients (54%) showed an improvement in the pure tone average (PTA) and 12 remained unchanged. The topical steroid therapy brought about an overall improvement in PTA of 13.5 +/- 7.3 dB for the 26 patients enrolled. The auditory capacity index, defined as the mean speech discrimination score obtained at 40, 55 and 70 dB, improved by 24.2 +/- 8.7% in 26 patients. Among the 12 patients with a stable PTA, 9 showed an increase in speech intelligibility. CONCLUSION: Local administration of steroids to the inner ear through the round window route improves hearing and speech intelligibility in patients after failure of conventional therapy.
Disciplines :
Otolaryngology
Author, co-author :
Barriat, Sebastien
van Wijck, France
Staecker, Hinrich
Lefèbvre, Philippe ; Université de Liège > Département des sciences cliniques > Oto-rhino-laryngologie et audiophonologie
Language :
English
Title :
Intratympanic steroid therapy using the Silverstein Microwick for refractory sudden sensorineural hearing loss increases speech intelligibility.
Battaglia A, Burchette R, Cueva R: Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol 2008; 29: 453-460.
Battista RA: Intratympanic dexamethasone for profound idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2005; 132: 902-905. (Pubitemid 40798414)
Byl FM Jr: Sudden hearing loss: eight years' experience and suggested prognostic table. Laryngoscope 1984; 94: 647-661. (Pubitemid 14105743)
Chandrasekhar SS, Rubinstein RY, Kwartler JA, Gatz M, Connelly PE, Huang E, Baredes S: Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg 2000; 122: 521-528. (Pubitemid 30210667)
Choung YH, Park K, Shin YR, Cho MJ: Intratympanic dexamethasone injection for refractory sudden sensorineural hearing loss: Laryngoscope 2006; 116: 747-752. (Pubitemid 44318031)
Dallan I, Bruschini L, Nacci A, Bruschini P, Traino C, Rognini F, Ferraro G, Bruschini P: Transtympanic steroids as a salvage therapy in sudden hearing loss: preliminary results (Pubitemid 44352662)
De Kleyn A: Sudden complete or partial loss of function of the octarus-system in apparently normal persons. Acta Otolaryngol 1944; 32: 407-429.
Gianoli GJ, Li JC: Transtympanic steroids for treatment of sudden hearing loss. Otolaryngol Head Neck Surg 2001; 125: 142-146. (Pubitemid 33662658)
Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF: Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2007; 117: 3-15. (Pubitemid 46066055)
Herr BD, Marzo SJ: Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2005; 132: 527-531. (Pubitemid 40460877)
Ho GM, Lin HG, Shu MT: Effectiveness of intratympanic dexamethasone injection in sudden deafness patients as salvage treatment. Laryngoscope 2004; 114: 1184-1189.
Lefebvre PP, Staecker H: Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy: a pilot study. Acta Otolaryngol 2002; 122: 698-702. (Pubitemid 35398879)
Moskowitz D, Lee KJ, Smith HW: Steroid use in idiopathic sudden sensorineural hearing loss. Laryngoscope 1984; 94: 664-666. (Pubitemid 14105745)
Parnes LS, Sun AH, Freeman DJ: Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999; 109: 1-17. (Pubitemid 29315126)
Plontke SK, Lowenheim H, Mertens J, Engel C, Meisner C, Weidner A, Zimmermann R, Preyer S, Koitschev A, Zenner HP: Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2009; 119: 359-369.
Rarey KE, Luttge WG: Presence of type I and type II/IB receptors for adrenocorticosteroid hormones in the inner ear. Hear Res 1989; 41: 217-221.
Saijo S, Kimura RS: Distribution of HRP in the inner ear after injection into the middle ear cavity. Acta Otolaryngol 1984; 97: 593-610. (Pubitemid 14122226)
Shaia FT, Sheehy JL: Sudden sensori-neural hearing impairment: a report of 1,220 cases. Laryngoscope 1976; 86: 389-398.
Silverstein H: Use of a new device, the Micro-Wick, to deliver medication to the inner ear. Ear Nose Throat J 1999; 78: 595-598, 600.
Slattery WH, Fisher LM, Iqbal Z, Friedman RA, Liu N: Intratympanic steroid injection for treatment of idiopathic sudden hearing loss. Otolaryngol Head Neck Surg 2005; 133: 251-259. (Pubitemid 41125677)
Van Wijck F, Staecker H, Lefebvre PP: Topical steroid therapy using the Silverstein Microwick in sudden sensorineural hearing loss after failure of conventional treatment. Acta Otolaryngol 2007; 127: 1012-1017. (Pubitemid 47463755)
Wilson WR, Byl FM, Laird N: The efficacy of steroids in the treatment of idiopathic sudden hearing loss: a double-blind clinical study. Arch Otolaryngol 1980; 106: 772-776. (Pubitemid 11194190)
Xenellis J, Papadimitriou N, Nikolopoulos T, Maragoudakis P, Segas J, Tzagaroulakis A, Ferekidis E: Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study. Otolaryngol Head Neck Surg 2006; 134: 940-945. (Pubitemid 43766563)